Stereotactic Biopsy

	Tweet

Choice of Guidance Modality
Stereotactic guidance is preferable for lesions evident as calcifications, as well as for masses that cannot be identified with ultrasound. For masses that can be seen with ultrasound, ultrasound-guided biopsy is faster, less expensive and does not use ionizing radiation; therefore it may be the method of choice, in such cases if the appropriate equipment and expertise are available.

Tissue-Acquisition Devices
Available tissue-acquisition devices include fine needles, automated core needles, directional vacuum-assisted probes and biopsy cannulas.

Although early work with image-guided biopsy was performed using fine needles, many centers have turned to larger tissue-acquisition devices because of the lower frequency of insufficient samples and the better characterization of benign and malignant lesions that is possible when a larger volume of tissue is obtained.

Previous studies of stereotactic core biopsy with a 14-gauge automated needle showed 87-96% concordance between results of stereotactic core biopsy and surgery.  Complications were rare, with the frequency of Hematoma and infection each approximately 1 in 1000.

A directional vacuum-assisted biopsy instrument is now available for performing imaging-guided biopsy, most often used with stereotactic guidance. Compared to the automated needle, the vacuum device acquires larger samples of tissue, has a higher frequency of retrieval of calcifications and may provide more accurate characterization of complex lesions such as those containing atypical ductal hyperplasia or ductal carcinoma in situ.

Choice of Tissue-Acquisition Device
Excellent results have been obtained using the 14-gauge automated needle for biopsy of masses under ultrasound or stereotactic guidance. For calcifications, several investigators have demonstrated a higher rate of calcification retrieval and more accurate lesion characterization using the directional vacuum-assisted biopsy probe than the automated needle.

The directional vacuum-assisted biopsy instrument may also be preferable for small lesions (e.g., 0.5 cm), because technology is available that allows accurate placement of a localizing clip through the biopsy probe to facilitate subsequent localization, if necessary. Further work is needed to determine if there is any benefit to the use of the larger biopsy cannulas that are now available.

Role of Imaging-Guided Biopsy in Diagnosis of Breast Disease
There are many patientcare advantages from using image-guided percutaneous breast biopsy.

Percutaneous biopsy is less invasive and less expensive than surgery. Less tissue is removed, so there is less resulting deformity in the breast and less scarring on subsequent mammograms. The biopsy can be performed rapidly, so there is less time lost from work or other activities.

Percutaneous biopsy is less expensive than surgery. Women who have percutaneous biopsy undergo fewer operations, regardless of whether the diagnosis is benign or malignant. Continued improvements in the technique for percutaneous biopsy will allow more women to take advantage of this alternative to surgery for the diagnosis of breast lesions.

Laura Liberman and Timothy L. Feng
Breast cancer detection demonstration project: five-year summary report. CA 2003

References

RELATED STORIES:
Hormone Receptor Sites   Breast cancer risk is increased in women with prenatal exposure to diethylstilbestrol   Breast Abscess   Granulomatous Lesions of the Breast   Future Hope for Patients with Breast Cancers Resistant to Tamoxifen   Follow-Up Care   Epithelial Hyperplasia   Radiation Therapy Conclusion   Tamoxifen Use and Endometrial Abnormalities   Conclusion - Biology of High Risk Benign Breast Lesions   Breast hematoma   Alternative Interventions for Management of Menopause   Modifying the risk associated with obesity   Prognosis   Sensitivity, Specificity, and Positive Predictive Value   Beyond CMF: The Use of Doxorubicin and Taxane-Containing Regimens   Curative Treatment - Recommendations   Surgical Approach   Fat Necrosis   The surgical management of breast cancer   Evaluation of Breast Cancer Screening   Experimental Model for human proliferative Breast Disease

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]